Contract notice CN4171505 · National Blood Authority
Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)
$318m
whole-of-life value
- Supplier
- Roche Products Pty Ltd ABN 70000132865
- Agency
- National Blood Authority
- Procurement method
- limited tender
- Reason given
- 10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.
- Term
- 2025-07-01 to 2028-06-30
- Published
- 2025-07-18
- Category (UNSPSC)
- 51000000
- Agency reference
- CBP-CON-00156
Value by financial year
The total value spread evenly from start to end date. estimate: annualised
| Financial year | Estimated amount |
|---|---|
| 2025-26 | $106m |
| 2026-27 | $106m |
| 2027-28 | $106m |
Published versions
Every version of this notice we have loaded; earlier versions have not been fetched yet. Source: AusTender OCDS API.
| Date | Version | Value |
|---|---|---|
| 2025-07-18 | original notice | $318m |